Introduction: Primary percutaneous coronary intervention (pPCI) has become the preferred reperfusion strategy in patients with ST-elevation myocardial infarction (STEMI). Previous research studies have shown that certain clinical and laboratory parameters can be associated with early mortality in patients with acute myocardial infarction treated by primary PCI. The Aim: The aim of our study was to determine the clinical and laboratory predictors of an adverse early prognosis of our patients with STEMI treated by primary PCI.
INTRODUCTION
Primary percutaneous coronary intervention (pPCI) has become the preferred reperfusion strategy in patients with ST-elevation myocardial infarction (STEMI) (STEMI) [1] [2] [3] [4] [5] . Compared with thrombolytic and conservative therapy, the application of pPCI reduced the intrahospital and late mortality rate in patients with STEMI, and the frequency of other early or late complications [6] .
Studies have shown that there are certain clinical and laboratory indicators of adverse outcome in patients aft er pPCI [4, 5, 6] . According to some authors' results, independent predictors of intrahospital mortality in patients with STEMI aft er pPCI are: age (patients older than 75 years), AMI complications with cardiogenic shock, the long time interval from pain onset to pPCI, comorbidities, previous cardiac and renal failure, high glucose levels and other laboratory fi ndings [6] [7] [8] .
THE AIM
Th e aim of our study was to determine the clinical and laboratory predictors that indicate an adverse early prognosis of our patients with STEMI treated by pPCI.
MATERIAL AND METHODS
Our study is IV phase, academic, observational, retrospective cross-sectional study comprises a total of. Th e study follows the Good Clinical Practice guidelines and is conducted in accordance with the provisions of the regulation of clinical trials in the Republic of Serbia [9] . Th e study included 180 consecutive patients who were hospitalized in the Coronary Care Unit of the Emergency Center, Clinical Center of Serbia, over 18 years of age, with clinical and electrocardiographic signs of acute STEMI, which lasted up to 12 hours aft er the symptom onset.
Criteria for inclusion of patients in the study are: -patients over the age of 18; -typical precordial pain lasting for more than 20 minutes; -time period from symptom onset to admission should not exceed 12 hours; -electrocardiography (ECG): ST elevation in at least two contiguous leads, measuring more than 0.2 mV in leads V2 and V3 or more than 0.1 mV in all other leads or new acute bundle branch block; -values of cardiac-specifi c markers (troponin) above the normal reference range (on admission and / or aft er 24 h);
Criteria for exclusion from the study: -non-consent by the patient to the invasive treatment; -contraindications to double-antiaggregation therapy or contrast media: active or recent internal bleeding, previous bleeding aft er the use of nonsteroidal antiinfl ammatory drugs, known hemorrhagic diathesis, allergy to contrast, intracranial tumor or aneurysm, platelet count of less than 100 000/mm3); -cardiogenic shock on admission;
Th e access for coronary angiography was via a. femoralis. Primary PCI and stent placement in occluded infarct-related artery (IRA) was performed according to standard techniques (visualization of non-occluded artery/non-infarction-related artery (non-IRA) with diagnostic 6 F catheter, visualization of the IRA with 6-F guiding catheter, angioplasty and stent placement of anatomically accessible places).
We analyzed the following clinical and laboratory variables recorded in an electronic database of the Emergency Center Coronary Care Unit CCU: age, gender, medical history, and risk factors (previous heart attack, hypertension, hyperlipidemia, diabetes), heart failure according to Killip-u> 1 on admission, systolic and diastolic blood pressure, heart rate frequency, hypotension on admission, hemoglobin levels, leukocytes, potassium, platelet count, creatine kinase, fi brinogen, creatinine, creatinine clearance (calculated by CockcroftGault Equation), admission glucose levels, acute bundle branch block, changes on lung X-rayand RTG enlarged cardiac silhouette.
Th e primary objective of the thesis was the intrahospital mortality.
Following statistical methods were used to process the obtained data: Clinical and laboratory characteristics of the groups are listed in Table 1 and  Table 2 Table 4) . Logistic regression analysis of clinical and laboratory variables registered on admission of patients has shown that the independent predictors of an early adverse prognosis are: diabetes, Killip>1 on admission, hypotension on admission, creatinine clearance <60 ccs/min (Table  3) , acute bundle branch block, whereas the age of the patient showed a trend toward statistical signifi cance (Table 5 ).
DISCUSSION
Our study showed that the degree of cardiac insuffi ciency according to Killip on admission (Killip>1), the occurrence of hypotension during hospitalization, creatinine values on admission, electrocardiographic recording of acute bundle branch block, as well as the presence of hyperlipidemia, represent the negative predictive factors in univariate analysis. In multivariate analysis, independent indicators of early mortality were diabetes, Killip>1 on admission, hypotension, creatinine clearance <60 ccs/min, acute bundle branch block; as the age of the patients showed a trend toward statistical signifi cance. Intrahospital mortality of patients in our study was 3.33 %, and it is consistent with the data from other Centers where the mortality was 2-5 %, but this percentage increases signifi cantly in higher risk rates patients [4] .
Bilkova et al. [5] and other authors' [6] researches showed that early prognosis of patients with STEMI treated by pPCI depends on clinical parameters of the so-called shock index (defi ned as the value of heart rate frequency and blood pressure on admission) and that the highest mortality rate was for the patients with cardiogenic shock (20.3 %), which is consistent with the results of our study which shows that the degree of heart failure according to Killip >1 (on patient's admission), is a negative predictive factor for an adverse early prognosis in multivariate analysis. A study which followed 30-day and one-year mortality of patients with AMI treated by this method showed that Killip >1 at admission [7] was a predictor of early as well as one-year mortality.
Many studies suggest that there are signifi cant gender diff erences in the outcome of patients treated by pPCI, with an adverse prognosis for the female gender, where the mortality rate of women was caused by the occurrence of heart insuffi ciency and cardiogenic shock [10] in the highest percentage. D' Ascenzo et al. indicate a higher incidence of death among females treated by pPCI, which is explained by the fact that women are usually elderly patients; furthermore, in the study group women signifi cantly more oft en suffered from diabetes mellitus [11] . But aft er 60 months of observation, a diff erence in death outcome between the sexes was not noted.
Our study shows that the age of patients is an independent prognostic factor, i.e. with advanced age increases the risk of early adverse outcomes in patients treated by pPCI, which is consistent with literature data [7, 8, 12] . Studies dealing with risk assessment and adverse events aft er pPCI using scoring systems [13] [14] [15] [16] give age a signifi cant impact as predictor of early adverse outcome, which was confi rmed in a meta-analysis that dealt with the comparison of these studies [16] . On the other hand Teplitsky et al. analysis showed that in patients older than 90 years, pPCI was associated with low mortality in clinically stable patients, while clinically unstable patients had much worse prognosis in a six-month followup [17] . Furthermore, a study of 102 patients older than 75 years indicates that the pPCI is safe and useful method of treatment, which contributes to the reduction of intrahospital and one-year mortality in these patients [18] .
Glycemia on admission was analyzed in many studies as a predictive factor in early, as well as late prognosis. In patients with diabetes, higher serum glucose level is associated with adverse prognosis and a higher mortality rate [7, 8, 14, 15, [19] [20] [21] [22] [23] [24] . In patients who were not suff ering from diabetes has been shown that high glucose level on admission has a signifi cant role as an independent predictive factor for early and late prognosis [21] . Th erefore, patients who don't have diabetes, with high glucose levels on admission, have 2.8
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Volume 3 • Number 3 • October 2016 • HOPH times higher death rate aft er 28 days of monitoring compared to the group of patients with diabetes mellitus with higher admission glycemia levels [22] . In our study, glucose levels on admission was not as signifi cant predictive factor of early adverse prognosis, which could be explained by the relatively small number of patients involved in research. However, the presence of diabetes correlated with a significantly adverse prognosis in comparison with the patients who don't have diabetes, which is consistent with other studies.
Creatinine value on admission in patients with AMI is an independent factor of early mortality, which is consistent with the data obtained in literature [20, [23] [24] [25] [26] , where serum creatinine higher than 1.5 mg/ dL showed a signifi cant indication of adverse prognosis. In one of stated works, the high uric acid levels, and renal failure correlated with adverse prognosis [25] . Zhang et al, showed that the high creatinine levels on admission (>115 micromol/l) in patients with STEMI treated by pPCI with DES stent implantation, was independent predictor of MACE (major cardiac events adverse) in the fi rst 90 days. Elevated levels of creatinine indicate abnormal hemodynamic status [27] . Our study showed that the mortality was recorded signifi cantly more in patients with creatinine clearance values less than 60 ccs/min, which represents an independent predictive factor of intrahospital mortality of these patients (Table 3) Our results indicate that hypotension is the factor of adverse prognosis, which may be explained by the higher incidence of heart failure (higher rate according to Killip) and cardiogenic shock in these patients, which represent negative prognostic factors. Th ese results are consistent with other studies [5, 13, 14, 16] .
Acute bundle branch block was an independent predictor of intrahospital mortality in multivariate analysis, which is consistent with results of other researches [5, 26] . Acute bundle branch block in patients with AMI is associated with the size of infarction zone, increased frequency of pulmonary edema (Killip III) and cardiogenic shock (Killip IV) [14] [15] [16] 27] .
Th e values of hemoglobin, creatine kinase, leukocyte count, potassium, fi brinogen, platelet count, as well as X-ray changes in the lungs and heart in our study did not show signifi cance as early prognostic factors, which is not consistent with data from the literature [28] [29] [30] . Numerous studies suggest that predictors of early and later mortality [14-16, 23, 32, 33] , are low hemoglobin (anemia) and elevated infl ammatory markers (leukocyte counts, high neutrophil-lymphocyte ratio, CRP). Discordance between the literature data and results of our studies in these clinical and laboratory parameters can be explained by the fact that this retrospective study was limited by the small number of patients included.
Our research has shown that the group of deceased patients had signifi cantly fewer smokers. Th e phenomenon of so-called "Smoker's paradox" has been investigated in other studies where a lower mortality aft er pPCI precisely in a group of active and former smokers, as compared with a group of nonsmokers, was explained by greater infl uence of other risk factors on the occurrence of AMI than the smoking status, as well as the fact that with smokers AMI occurs almost a decade earlier [8, 34] .
Th e results obtained in this study are consistent with the results of other studies that were conducted on signifi cantly higher number of patients. Predictors of early mortality obtained in this study represent signifi cant parameters in determining the scores [13] [14] [15] [16] of patients with STEMI treated by pPCI, and are used in order to achieve adequate clinical evaluation of these patients. Adequate risk assessment early aft er pPCI can enable the application of appropriate measures and procedures that would be aimed to reduce or prevent unwanted course and outcome of the illness.
Study limitations
Th e number of deceased is very small. With such small number of these cases their representivity is questionable. Also, logistic model validation and/or bootstrapping is not performed.
CONCLUSION
Our study showed that diabetes, Killip>1 on admission, hypotension, creatinine clearance <60 ccs/min and acute bundle branch block represent the independent clinical and laboratory parameters of early mortality in patients with STEMI treated by pPCI.
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